Asif Ali sold $1.5M of PTGX
Chief Financial Officer at Protagonist Therapeutics, Inc. 24,903 shares at an average of $58.73, traded Mar 12, 2025, filed Mar 14, 2025.
Score components
- +22RoleCFO
- +25Trade size$1.5M at market
- +10Share of holdings soldSold 28% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-024062, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 12, 2025 | MOption exercise Common Stock | +15,203 | $12.17 | $185k | 78,024 | Mar 14, 2025 |
| Mar 12, 2025 | MOption exercise Common Stock | +9,700 | $19.19 | $186k | 87,724 | Mar 14, 2025 |
| Mar 12, 2025 | SOpen-market sale Common Stock | -24,903 | $58.73 | $1.5M | 62,821 | Mar 14, 2025 |
| Mar 12, 2025 | MOption exercise Stock Option (right to buy)derivative | -15,203 | $0.00 | $0 | 30,547 | Mar 14, 2025 |
| Mar 12, 2025 | MOption exercise Stock Option (right to buy)derivative | -9,700 | $0.00 | $0 | 66,800 | Mar 14, 2025 |
Related signals
Other insiders at Protagonist Therapeutics, Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | Protagonist Therapeutics, Inc | Asif Ali Chief Financial Officer | $8.3M 58,629 shares | -50% | |
| 20Weak | Protagonist Therapeutics, Inc | Dinesh Ph D Patel V President and CEO | $18M 125,000 shares | -22% | |
| 57Moderate | Protagonist Therapeutics, Inc | Asif Ali Chief Financial Officer | $2.6M 24,765 shares | -29% | |
| 45Moderate | Protagonist Therapeutics, Inc | Arturo Molina Md Chief Medical Officer | $1.6M 15,000 shares | -15% | |
| 50Moderate | Protagonist Therapeutics, Inc | Harold E Selick director | $2.5M 24,000 shares | -28% | |
| 55Moderate | Protagonist Therapeutics, Inc | Dinesh Ph D Patel V President and CEO | $5.5M 54,700 shares | -10% | |
| 53Moderate | Protagonist Therapeutics, Inc | Lewis T Williams director | $1.5M 18,000 shares | -70% | |
| 60Notable | Protagonist Therapeutics, Inc | William D. Waddill director | $1.7M 20,000 shares | -72% | |
| 57Moderate | Protagonist Therapeutics, Inc | Asif Ali Chief Financial Officer | $3.8M 46,203 shares | -43% | |
| 45Moderate | Protagonist Therapeutics, Inc | Arturo Molina Md Chief Medical Officer | $1.9M 23,151 shares | -24% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.